Losartan promotes cell survival following SARS-CoV-2 infection in vitro
R. Nejat, A. S. Sadr, B. T. Freitas, J. Crabtree, S. D. Pegan, R. A. Tripp, D. J. Najafi
This study shows that Losartan reduces SARS-CoV-2 replication in Vero E6 cells by 80% pre-infection and 70% post-infection, promoting cell survival with low side-effects.
bioRxiv · Dec 27, 2020 · PreprintPharmacology & Toxicology